Research shows differences in orphan drug availability in Europe
A study suggests that the availability of orphan drugs varies significantly between different...
Trending:
A study suggests that the availability of orphan drugs varies significantly between different...
A study suggests that the availability of orphan drugs varies significantly between different countries in Europe.
Baccinex has entrusted Telstar with the design and construction of a cleanroom installation to accommodate an aseptic and lyophilised filling process line, enlarging the existing pharmaceutical plant in the Switzerland region of Jura.
The US had the largest pharmaceutical market revenue in 2017, and is expected to continue to do so for the foreseeable future.
Johnson & Johnson’s (J&J) Tremfya (guselkumab) has recently been granted approval for the treatment of adults suffering from moderate-to-severe plaque psoriasis in Australia, Brazil, and Japan. J&J has licensed Tremfya to MorphoSys in these respective regions.
It is through communication that a company presents itself to the world. They are its voice and create its image, anywhere and in any language. Wherever you want to get your message across, interlanguage is by your side.
Despite the highly competitive nature of the immunology drugs market there are several well-established blockbuster drugs that dominate in terms of revenue.
Takeda Pharmaceutical Company has put forward a fourth offer to acquire Shire, a day after the Irish biopharmaceutical company best known for ADHD drug Adderall rejected a previous offer.
Nutrition is a trending topic for consumers today, but taste, convenience and ease-of-use are also influencing purchasing decisions.
The US Food and Drug Administration (FDA) has awarded breakthrough therapy designation to Pfizer’s Trumenba for meningococcal B disease in children aged between one and nine.
Belgian biopharmaceutical company UCB has acquired an anti-epilepsy medication, Midazolam nasal spray (USL261), from Proximagen for $150m.
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.
Go Top